308 related articles for article (PubMed ID: 28283175)
21. [Clinical course and treatment of ectopic atrial tachycardia in 144 children].
Ge H; Li X; Zhang Y; Liu H; Jiang H
Zhonghua Er Ke Za Zhi; 2015 Mar; 53(3):214-9. PubMed ID: 26165020
[TBL] [Abstract][Full Text] [Related]
22. Is hospital admission for initiation of antiarrhythmic therapy with sotalol for atrial arrhythmias required? Yield of in-hospital monitoring and prediction of risk for significant arrhythmia complications.
Chung MK; Schweikert RA; Wilkoff BL; Niebauer MJ; Pinski SL; Trohman RG; Kidwell GA; Jaeger FJ; Morant VA; Miller DP; Tchou PJ
J Am Coll Cardiol; 1998 Jul; 32(1):169-76. PubMed ID: 9669266
[TBL] [Abstract][Full Text] [Related]
23. Clinical comparison of ibutilide and propafenone for converting atrial flutter.
Sun JL; Guo JH; Zhang N; Zhang HC; Zhang P
Cardiovasc Drugs Ther; 2005 Jan; 19(1):57-64. PubMed ID: 15883757
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine.
Hohnloser SH; van de Loo A; Baedeker F
J Am Coll Cardiol; 1995 Oct; 26(4):852-8. PubMed ID: 7560608
[TBL] [Abstract][Full Text] [Related]
25. Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness.
Wang J; Bourne GW; Wang Z; Villemaire C; Talajic M; Nattel S
Circulation; 1993 Sep; 88(3):1030-44. PubMed ID: 8353865
[TBL] [Abstract][Full Text] [Related]
26. Adverse event rate during inpatient sotalol initiation for the management of supraventricular and ventricular tachycardia in the pediatric and young adult population.
Chandler SF; Chu E; Whitehill RD; Bevilacqua LM; Bezzerides VJ; DeWitt ES; Alexander ME; Abrams DJ; Triedman JK; Walsh EP; Mah DY
Heart Rhythm; 2020 Jun; 17(6):984-990. PubMed ID: 32014568
[TBL] [Abstract][Full Text] [Related]
27. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
Joseph AP; Ward MR
Ann Emerg Med; 2000 Jul; 36(1):1-9. PubMed ID: 10874228
[TBL] [Abstract][Full Text] [Related]
28. Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry.
Luedtke SA; Kuhn RJ; McCaffrey FM
Ann Pharmacother; 1997 Oct; 31(10):1227-43. PubMed ID: 9337449
[TBL] [Abstract][Full Text] [Related]
29. The efficacy and safety of intravenous propafenone versus intravenous amiodarone in the conversion of atrial fibrillation or flutter after cardiac surgery.
Larbuisson R; Venneman I; Stiels B
J Cardiothorac Vasc Anesth; 1996 Feb; 10(2):229-34. PubMed ID: 8850403
[TBL] [Abstract][Full Text] [Related]
30. Sotalol versus propafenone for long-term maintenance of normal sinus rhythm in patients with recurrent symptomatic atrial fibrillation.
Kochiadakis GE; Igoumenidis NE; Hamilos ME; Tzerakis PG; Klapsinos NC; Chlouverakis GI; Vardas PE
Am J Cardiol; 2004 Dec; 94(12):1563-6. PubMed ID: 15589019
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and proarrhythmia of oral sotalol in pediatric patients.
Pfammatter JP; Paul T; Lehmann C; Kallfelz HC
J Am Coll Cardiol; 1995 Oct; 26(4):1002-7. PubMed ID: 7560592
[TBL] [Abstract][Full Text] [Related]
32. Placebo-controlled evaluations of propafenone for atrial tachyarrhythmias.
Rae AP
Am J Cardiol; 1998 Oct; 82(8A):59N-65N. PubMed ID: 9809902
[TBL] [Abstract][Full Text] [Related]
33. [Electrophysiologic effects of diprafenone in supraventricular and ventricular tachycardia].
Manz M; Beermann J; Gerckens U; Lüderitz B
Z Kardiol; 1986 Dec; 75(12):757-63. PubMed ID: 3825226
[TBL] [Abstract][Full Text] [Related]
34. [Propafenone and sotalol: long-term efficacy and tolerability in the prevention of paroxysmal atrial fibrillation. A placebo-controlled double-blind study].
Bellandi F; Dabizzi RP; Niccoli L; Cantini F; Palchetti R
G Ital Cardiol; 1996 Apr; 26(4):379-90. PubMed ID: 8707022
[TBL] [Abstract][Full Text] [Related]
35. Safety of oral propafenone in the treatment of arrhythmias in infants and children (European retrospective multicenter study). Working Group on Pediatric Arrhythmias and Electrophysiology of the Association of European Pediatric Cardiologists.
Janousek J; Paul T
Am J Cardiol; 1998 May; 81(9):1121-4. PubMed ID: 9605053
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of sotalol for atrial flutter in children after surgery for congenital heart disease.
Beaufort-Krol GC; Bink-Boelkens MT
Am J Cardiol; 1997 Jan; 79(1):92-4. PubMed ID: 9024748
[TBL] [Abstract][Full Text] [Related]
37. Conversion of recent onset atrial fibrillation with single loading oral dose of propafenone: is in-hospital admission absolutely necessary?
Botto GL; Bonini W; Broffoni T; Molteni S; Lombardi R; Alfieri G; Barone P; Bernasconi G; Ferrari G
Pacing Clin Electrophysiol; 1996 Nov; 19(11 Pt 2):1939-43. PubMed ID: 8945073
[TBL] [Abstract][Full Text] [Related]
38. [Effects of amiodarone versus sotalol in treatment of atrial fibrillation: a random controlled clinical study].
Niu F; Huang CX; Jiang H; Yang B; Guo WL; Chen YX; Jin CR; Liu ZM
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):121-3. PubMed ID: 16620720
[TBL] [Abstract][Full Text] [Related]
39. Ibutilide: efficacy and safety in atrial fibrillation and atrial flutter in a general cardiology practice.
Eversole A; Hancock W; Johns T; Lopez LM; Conti CR
Clin Cardiol; 2001 Jul; 24(7):521-5. PubMed ID: 11444644
[TBL] [Abstract][Full Text] [Related]
40. [Use of propafenone in emergency therapy].
Liguori A; Pellegrino G; Di Ieso N; Piatto A; Ruggiero P; Scarnera P; Guardascione A
Clin Ter; 1989 Dec; 131(5):307-14. PubMed ID: 2532584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
